Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Alaunos Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$6.44 | -$6.44 | -$6.44 |
| Q2 2025 | 1 | -$5.33 | -$5.33 | -$5.33 |
| Q3 2025 | 1 | -$4.90 | -$4.90 | -$4.90 |
| Q4 2025 | 1 | -$3.69 | -$3.69 | -$3.69 |
Alaunos Therapeutics, Inc. Earnings Date And Information
Alaunos Therapeutics, Inc. last posted its earnings results on Monday, March 31st, 2025. The company reported $-0.46339 earnings per share for the quarter, topping analysts' consensus estimates of $-4.5 by $4.03661. The company had revenue of 4.00 K for the quarter and had revenue of 10.00 K for the year. Alaunos Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-2.92 diluted earnings per share) and currently has a price-to-earnings ratio of -0.99. Alaunos Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based on prior year's report dates.
Alaunos Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/30/2025 | Q4 2024 | N/A | -$0.46 | N/A | $4.00 K | $4.00 K |
| 11/14/2024 | Q3 2024 | -$4.50 | -$0.70 | 3.8 | $0 | $0 |
| 08/14/2024 | Q2 2024 | -$4.50 | -$0.71 | 3.79 | $4.00 K | $4.00 K |
| 05/15/2024 | Q1 2024 | -$4.50 | -$1.05 | 3.45 | N/A | $1.00 K |
| 04/01/2024 | Q4 2023 | N/A | -$4.90 | N/A | N/A | $1.00 K |
| 09/29/2023 | Q3 2023 | N/A | -$5.30 | N/A | N/A | $0 |
| 08/14/2023 | Q2 2023 | -$6.00 | -$5.49 | 0.51 | N/A | $4.00 K |
| 05/10/2023 | Q1 2023 | -$6.00 | -$5.85 | 0.15 | N/A | $0 |
| 03/07/2023 | Q4 2022 | -$13.49 | -$6.58 | 6.91 | N/A | $11.00 K |
| 11/14/2022 | Q3 2022 | -$17.99 | -$6.58 | 11.41 | N/A | $2.91 M |
| 08/15/2022 | Q2 2022 | -$16.49 | -$6.84 | 9.65 | N/A | $0 |
| 05/16/2022 | Q1 2022 | -$13.49 | -$7.32 | 6.17 | N/A | $0 |
| 03/30/2022 | Q4 2021 | -$13.49 | -$8.24 | 5.25 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.13 | -$15.89 | -15.76 | N/A | $398.00 K |
| 08/13/2021 | Q2 2021 | -$0.12 | -$15.86 | -15.74 | N/A | $0 |
| 05/06/2021 | Q1 2021 | -$0.10 | -$15.11 | -15.01 | N/A | $0 |
| 03/01/2021 | Q4 2020 | N/A | -$16.03 | N/A | N/A | $0 |
| 11/05/2020 | Q3 2020 | -$0.09 | -$14.32 | -14.23 | N/A | $0 |
| 08/06/2020 | Q2 2020 | -$0.09 | -$13.11 | -13.02 | N/A | $0 |
| 05/07/2020 | Q1 2020 | -$0.08 | -$13.73 | -13.65 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alaunos Therapeutics, Inc. Earnings: FAQ's
Alaunos Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based offlast year's report dates.
In the previous quarter, Alaunos Therapeutics, Inc. (:TCRT) reported $-0.46339 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.5 by $4.03661.
The conference call for Alaunos Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Alaunos Therapeutics, Inc.'s latest earnings report can be read online.
Alaunos Therapeutics, Inc. (:TCRT) has a recorded annual revenue of $10.00 K.
Alaunos Therapeutics, Inc. (:TCRT) has a recorded net income of $-4,679,000.Alaunos Therapeutics, Inc. has generated $-2.92 earnings per share over the last four quarters.
Alaunos Therapeutics, Inc. (:TCRT) has a price-to-earnings ratio of -0.99 and price/earnings-to-growth ratio is -0.02.